异动解读 | 美国疫苗顾问放弃质疑mRNA疫苗,Moderna盘中大涨5.04%

异动解读
Mar 11

Moderna (MRNA) 今日盘中股价大幅上涨5.04%,引起了市场的广泛关注。

消息面上,据《华盛顿邮报》报道,美国联邦政府的一个重要疫苗顾问小组已放弃反对COVID mRNA疫苗。报道称,卫生与公众服务部部长小罗伯特·肯尼迪领导下的一些疫苗顾问曾寻求停止推荐mRNA疫苗,但该计划已不再推进。这一进展消除了市场对mRNA疫苗政策前景的部分担忧,对Moderna等主要生产商构成利好。

Moderna与辉瑞-生物技术公司是mRNA COVID-19疫苗的主要生产商。美国疾控中心顾问定于下周召开会议,预计将就疫苗建议提出意见,市场正密切关注后续进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10